Altered characteristics of silica nanoparticles in bovine and human serum: The importance of nanomaterial characterization prior to its toxicological evaluation

Particle and Fibre Toxicology

Volumn 10, Issue 1, 2013, Pages

  Izak Nau, Emilia ^a,b   Voetz, Matthias ^a   Eiden, Stefanie ^a   Duschl, Albert ^b   Puntes, Victor F ^c  

^a BAYER AG   (Germany)

^b UNIVERSITY OF SALZBURG   (Austria)

^c CATALAN INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY ICN2   (Spain)

Author keywords

Nanocharacterization; Protein corona; Silica nanoparticles; Stability

Indexed keywords

NANOPARTICLE; SILICA NANOPARTICLE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD SAMPLING; COW; HUMAN; INCUBATION TIME; IONIC STRENGTH; LIGHT SCATTERING; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NANOANALYSIS; NANOTOXICOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; SURFACE PROPERTY; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALIA; BOVINAE;

ANIMALS; CATTLE; CULTURE MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; SILICON DIOXIDE;

EID: 84887378505     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-10-56     Document Type: Article

References (69)

1. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 2003, 100:13549-13554. 10.1073/pnas.2232479100, 263851, 14597719.
2. Moghimi SM, Hunter AC, Murray JC. Nanomedicine: current status and future prospects. FASEB J 2005, 19:311-330. 10.1096/fj.04-2747rev, 15746175.
3. Ravi Kumar MNV, Sameti M, Mohapatra SS, Kong X, Lockey RF, Bakowsky U, Lindenblatt G, Schmidt CH, Lehr M. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J Nanosci Nanotechnol 2004, 4:876-881. 10.1166/jnn.2004.120, 15570975.
4. Slowing II, Vivero-Escoto JL, Wu CW, Lin VS. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 2008, 60:1278-1288. 10.1016/j.addr.2008.03.012, 18514969.
5. Vijayanathan V, Thomas T, Thomas TJ. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Biochemistry 2002, 41:14085-14094. 10.1021/bi0203987, 12450371.
6. He X, Wang K, Tan W, Liu B, Lin X, He C, Li D, Huang S, Li J. Bioconjugated nanoparticles for DNA protection from cleavage. J Am Chem Soc 2003, 125:7168-7169. 10.1021/ja034450d, 12797777.
7. Tapec R, Zhao JX, Tan W. Development of organic dye-doped silica nanoparticle for bioanalysis and biosensors. J Nanosci Nanotechnol 2002, 2:405-409. 10.1166/jnn.2002.114, 12908270.
8. Qhobosheane M, Santra S, Zhang P, Tan WH. Biochemically functionalized silica nanoparticles. Analyst 2001, 126:1274-1278. 10.1039/b101489g, 11534592.
9. Wang L, Tan WH. Multicolor FRET silica nanoparticles by single wavelength excitation. Nano Lett 2006, 6:84-88. 10.1021/nl052105b, 2527125, 16402792.
10. Zhao JX, Tapec-Dytioco R, Tan WH. Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles. J Am Chem Soc 2003, 125:11474-11475. 10.1021/ja0358854, 13129331.
11. Zhao JX, Hilliard LR, Mechery SJ, Wang Y, Bagwe RP, Jin S, Tan W. A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci USA 2004, 101:15027-15032. 10.1073/pnas.0404806101, 524056, 15477593.
12. Walcarius A, Ganesan V. Ion-exchange properties and electrochemical characterization of quaternary ammonium-functionalized silica microspheres obtained by the surfactant template route. Langmuir 2006, 22:469-477. 10.1021/la051916s, 16378461.
13. Han L, Sakamoto Y, Che S, Terasaki O. Insight into the defects of cage-type silica mesoporous crystals with Fd3m symmetry: TEM observations and a new proposal of 'polyhedron packing' for the crystals. Chemistry 2009, 15:818-825.
14. Ow H, Larson DR, Srivastava M, Baird BA, Webb WW, Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett 2005, 5:113-117. 10.1021/nl0482478, 15792423.
15. Mailänder V, Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 2009, 10:2379-2400. 10.1021/bm900266r, 19637907.
16. Stark WJ. Nanoparticles in biological systems. Angew Chem Int Ed Engl 2011, 50:1242-1258. 10.1002/anie.200906684, 21290491.
17. Limbach LK, Bereiter R, Müller E, Krebs R, Gäli R, Stark WJ. Removal of oxide nanoparticles in a model wastewater treatment plant: Influence of agglomeration and surfactants on clearing efficiency. Environ Sci Technol 2008, 42:5828-5833. 10.1021/es800091f, 18754516.
18. Lynch I, Cedervall T, Lundqvist M, Cabaleiro-Lago C, Linse S, Dawson KA. The nanoparticle - protein complex as a biological entity; a complex fluids and surface science challenge for the 21st century. Adv Colloid Interfac 2007, 134:167-174.
19. Wilhelm C, Billotey C, Roger J, Pons JN, Bacri JC, Gazeau F. Intracellular uptake of anionic superparamagnetic nanoparticles as a function of their surface coating. Biomaterials 2003, 24:1001-1011. 10.1016/S0142-9612(02)00440-4, 12504522.
20. Jansch M, Stumpf P, Graf CM, Rühl E, Müller RH. Adsorption kinetics of plasma proteins on ultrasmall superparamagnetic iron oxide (USPIO) nanoparticles. Int J Pharm 2012, 428:125-133. 10.1016/j.ijpharm.2012.01.060, 22342465.
21. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv. Drug Delivery Rev 2009, 61:428-437.
22. Ge C, Du J, Zhao L, Wang L, Liu Y, Li D, Yang Y, Zhou R, Zhao Y, Chai Z, Chen C. Binding of blood proteins to carbon nanotubes reduces cytotoxicity. Proc Natl Acad Sci 2011, 108:16968-16973. 10.1073/pnas.1105270108, 3193254, 21969544.
23. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Koller M, Epple M. The influence of proteins on the dispersability and cell biological activity of silver nanoparticles. J Mater Chem 2010, 20:512-518.
24. Orts-Gil G, Natte K, Drescher D, Bresch H, Mantion A, Kneipp J, Osterle W. Characterisation of silica nanoparticles prior to in vitro studies: from primary particles to agglomerates. J Nanopart Res 2011, 13:1593-1604.
25. Treuel L, Nienhaus GU. Toward a molecular understanding of nanoparticle-protein interactions. Biophys Rev 2012, 4:137-147.
26. Walczyk D, Baldelli-Bombelli F, Monopoli MP, Lynch I, Dawson KA. What the cell 'sees' in bionanoscience. J Am Chem Soc 2010, 132:5761-5768. 10.1021/ja910675v, 20356039.
27. Leszczynski J. Bionanoscience: nano meets bio at the interface. Nat Nanotechnol 2010, 5:633-634. 10.1038/nnano.2010.182, 20818408.
28. Moreau JW, Weber PK, Martin MC, Gilbert B, Hutcheon ID, Banfield JF. Extracellular proteins limit the dispersal of biogenic nanoparticles. Science 2007, 316:1600-1603. 10.1126/science.1141064, 17569859.
29. Luck M, Pistel KF, Li YX, Blunk T, Muller RH, Kissel T. Plasma protein adsorption on biodegradable microspheres consisting of Poly(D, L-lactide-co-glycolide), Poly(L-lactide) or ABA triblock copolymers containing Poly(oxyethylene)-Influence of production method and polymer composition. J Controlled Release 1998, 55:107-120.
30. Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk TM, Muller RH. 'Stealth' corona core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B 2000, 18:301-313.
31. Gessner A, Lieske A, Paulke BR, Muller RH. Functional groups on polystyrene model nanoparticles: influence on protein adsorption. J Biomed Mater Res, Part A 2003, 65:319-326.
32. Gessner A, Waicz R, Lieske A, Paulke BR, Mader K, Muller RH. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm 2000, 196:245-249. 10.1016/S0378-5173(99)00432-9, 10699728.
33. Thode K, Luck M, Semmler W, Muller RH, Kresse M. Determination of plasma protein adsorption on magnetic iron oxides: sample preparation. Pharm Res 1997, 14:905-910. 10.1023/A:1012104017761, 9244148.
34. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticles size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008, 105:14265-14270. 10.1073/pnas.0805135105, 2567179, 18809927.
35. Cedervall T, Lynch I, Foy M, Berggård T, Donnelly SC, Cagney G, Linse S, Dawson KA. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 2007, 46:5754-5756.
36. Faunce TA, White J, Matthaei KI. Integrated research into the nanoparticle-protein corona: a new focus for safe, sustainable, and equitable development of nanomedicines. Nanomedicine 2008, 3:859-866. 10.2217/17435889.3.6.859, 19025459.
37. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Time evolution of the nanoparticle protein corona. ACS Nano 2010, 4:3623-3632. 10.1021/nn901372t, 20553005.
38. Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V. Hardening of the nanoparticle-protein corona in metal (Au, Ag) and oxide (Fe3O4, CoO, and CeO2) nanoparticles. Small 2011, 7:3479-3486. 10.1002/smll.201101511, 22058075.
39. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007, 104:2050-2055. 10.1073/pnas.0608582104, 1892985, 17267609.
40. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Baldelli-Bombelli F, Dawson KA. Physico-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011, 133:2525-2534. 10.1021/ja107583h, 21288025.
41. Oberdörster G, Stone V, Donaldson K. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 2007, 1:2-25.
42. Drescher D, Orts-Gil G, Laube G, Natte K, Veh RW, Osterle W, Kneipp J. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Anal Bioanal Chem 2011, 400:1367-1373. 10.1007/s00216-011-4893-7, 21479547.
43. Rejman J, Zuhorn Ans IS, Oberle V, Hoekstra D. Size dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem J 2004, 377:159-169. 10.1042/BJ20031253, 1223843, 14505488.
44. Clift MD, Bhattacharjee S, Brown DM, Stone V. The effects of serum on the toxicity of manufactured nanoparticles. Toxicol Lett 2010, 198:358-365. 10.1016/j.toxlet.2010.08.002, 20705123.
45. Tedja R, Lim M, Amal R, Marquis C. Effects of serum adsorption on cellular uptake profile and consequent impact of titanium dioxide nanoparticles on human lung cell lines. ACS Nano 2012, 6:4083-4093. 10.1021/nn3004845, 22515565.
46. Mortensen NP, Hurst GB, Wang W, Foster CM, Nallathamby PD, Retterer ST. Dynamic development of the protein corona on silica nanoparticles: composition and role in toxicity. Nanoscale 2013, 5:6372-6380. 10.1039/c3nr33280b, 23736871.
47. Izak-Nau E, Kenesei K, Murali K, Voetz M, Eiden S, Puntes VF, Duschl A, Madarász E. Interaction of differently functionalized fluorescent silica nanoparticles with neural stem- and tissue-type cells. Nanotoxicology 2013, ID:864427 DOI:10.3109/17435390.2013.864427.
48. Jiang J, Oberdöster G, Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 2009, 11:77-99.
49. Monopoli MP, Baldelli-Bombelli F, Dawson KA. Nanoparticle coronas take shape. Nat Nanotechnol 2011, 6:11-12. 10.1038/nnano.2010.267, 21179098.
50. Long TC, Saleh N, Tilton RD, Lowry GV, Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ Sci Technol 2006, 40:4346-4352. 10.1021/es060589n, 16903269.
51. Kretzschmar R, Holthoff H, Sticher H. Influence of pH and humic acid on coagulation kinetics of kaolinite: a dynamic light scattering study. J Colloid Interface Sci 1998, 202:95-103.
52. Burns JL, Yan YD, Jameson GJ, Biggs S. A light scattering study of the fractal aggregation behavior of a model colloidal system. Langmuir 1997, 13:6413-6420.
53. Zhang D, Wang H, Neumann O, Barhoumi A, Perham M, Hartgerink J, Wittung-Stafshede P, Halas NJ. Gold nanoparticles can induce the formation of protein-based aggregates at physiological pH. Nano Lett 2009, 9:666-671. 10.1021/nl803054h, 19199758.
54. Vroman L. Effect of adsorbed proteins on the wettability of hydrophilic and hydrophobic solids. Nature 1962, 196:476-477. 10.1038/196476a0, 13998030.
55. Mu X, Li Z, Li X, Mishra SR, Zhang B, Si Z, Yang L, Jiang W, Yan B. Characterization of protein clusters of diverse magnetic nanoparticles and their dynamic interactions with human cells. J Phys Chem C 2009, 113:5390-5395.
56. Brewer SH, Glomm WR, Johnson MC, Knag MK, Franzen S. Probing BSA binding to citrate-coated gold nanoparticles and surfaces. Langmuir 2005, 21:9303-9307. 10.1021/la050588t, 16171365.
57. Carter DC, Ho JX. Structure of Serum-Albumin. Adv Protein Chem 1994, 45:153-203.
58. Peters T. All About Albumin: Biochemistry, Genetics, And Medical Applications 1996, San Diego: Academic Press.
59. Dayhoff MO, Eck RV, Chang MA, Sochard MR. Atlas of Protein Sequence and Structure 1965, Silver Spring, Maryland: National Biomedical Research Foundation.
60. Cho WS, Duffin R, Thielbeer F, Bradley M, Megson IL, MacNee W, Poland CA, Tran CL, Donaldson K. Zeta potential and solubility to toxic ions as mechanisms of lung inflammation caused by metal/metal-oxide nanoparticles. Toxicol Sci 2012, 126:469-477. 10.1093/toxsci/kfs006, 22240982.
61. Gasser M, Rothen-Rutishauser B, Krug HF, Gehr P, Nelle M, Yan B, Wick P. The adsorption of biomolecules to multi-walled carbon nanotubes is influenced by both pulmonary surfactant lipids and surface chemistry. J Nanobiotechnol 2010, 8:31.
62. Lundqvist M, Stigler J, Cedervall T, Berggård T, Flanagan MB, Lynch I, Elia G, Dawson K. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011, 5:7503-7509. 10.1021/nn202458g, 21861491.
63. Schleh C, Semmler-Behnke M, Lipka J, Wenk A, Hirn S, Schäffler M, Schmid G, Simon U, Kreyling WG. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012, 6:36-46. 10.3109/17435390.2011.552811, 3267526, 21309618.
64. Stöber W, Fink A, Bohn EJ. Controlled growth of monodisperse silica spheres in the micron size range. J Colloid Interface Sci 1868, 26:62-69.
65. Cassidy PE, Yager BJ. A review of coupling agents as adhesion promoter. J Macromol Sci Rev Polym Technol 1971, D1:1-48.
66. Arkels B. Tailoring surfaces with silanes. Chem Technol 1977, 7:766-776.
67. Plueddeman E. Silane Coupling Agents 1982, New York: Plenum Press.
68. Shapiro AL, Viñuela E, Maizel JV. Molecular weight estimation of polypeptide chains by electrophoresis in SDS-polyacrylamide gels. Biochem Biophys Res Commun 1967, 28:815-820. 10.1016/0006-291X(67)90391-9, 4861258.
69. Abramoff MD, Magalhães PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 2004, 11:36-42.